Global Clinical Trial Supplies Market is Valued at ~$2.5 billion in 2021 and is expected to grow at a CAGR of ~8% by 2026

1
Clinical Trial Supplies Market Top Scenario,
Business Overview Forecast to 2026
2
Services including packaging and labelling,
clinical supplies logistics distribution,
comparator sourcing, and clinical supplies
management are all part of the clinical trial
supplies (CTS) market. The RD expenditure by
large pharma companies totalled a record 133
billion in 2021, an increase of 44 since 2016.
With the rising RD spending and the increasing
complexity of clinical trials, Pharma/Biotech is
looking to outsource more non-core activities
related to clinical trials. Big Pharma is usually
more reluctant to outsource than biotech, which
is highly reliant on external partners for
clinical development activities. The global
clinical trial supplies market is valued at 2.5
billion in 2021 and is expected to grow at a CAGR
of 8, driven by rising RD expenditure,
increasing clinical trial complexity and
regulatory requirements, robust Venture Capital
activity in the Biotech sector, a growing trend
towards outsourcing, and growth in clinical
trials conducted. Increased Focus on Biologics
which require Specialized Logistics
Capabilities  The biologics market which is
rising at 15 far exceeds the overall pharma
market growth. Biologics drugs require
specialized logistics, distribution, storage, and
monitoring capabilities as drugs are temperature
sensitive. This further offers growth
opportunities for CTS providers with proven
expertise and capabilities in handling biologics.
3
Evolution in Clinical Trials Conducted In 2021,
new clinical trials started, across Phase
I/II/III, representing a 21 increase over the
previous year. Between 2016 and 21, the total
number of new clinical trials began increased by
7.1. The progress in the clinical trials
conducted would spur the demand for the clinical
trial supply services like comparator sourcing,
clinical logistics and supplies
management. Oncology High Growth Therapeutic
Area for CTS Oncology is the leading and
fastest-growing segment in terms of therapeutic
usage. This is mostly attributed to the presence
of a huge RD pipeline of oncology drugs.
Additionally, the majority of oncology drugs
require temperature-sensitive distribution, which
is anticipated to fuel the demand for cold chain
distribution. Decentralized Trials leading to
Increased Demand for CTS Covid-19 has provided an
impetus to clinical trials being conducted in a
decentralized manner. Virtual trials have become
more important than ever post-pandemic. There
were hardly any MAs related to virtual trials
taking place before the pandemic, but the market
observed 10 MA deals in 2020. The rising trend
toward decentralized trials and the requirement
for direct-from-patient and direct-to-patient
logistics and distribution of samples/drugs/monito
ring equipment make the role of CTS providers
more critical in guaranteeing smooth efficient
progress of clinical studies.
4

• Explore Premium Report on Clinical Trial Supplies
  Market _at_ https//meditechinsights.com/clinical-tri
  al-supplies-market/
• Global Footprint and Coverage, a Key
  Differentiator
• As companies face challenges in the recruitment
  of patients, clinical trials are progressively
  conducted across more regions and sites. CTS
  providers with a global footprint and/or ability
  to service across North America/Europe and
  increasingly Asia/LATAM as well, are in great
  demand.
• Global Expansion and Acquisition Witnessed as Key
  Growth Strategies
• As a key growth strategy, companies in the
  clinical trial supplies market are concentrating
  on growing their global presence with additional
  office footprint and/or entering into
  acquisitions to broaden their existing service
  offerings.
• For instance,
• In June 2021, Biocair opened a new facility in
  Frankfurt (Germany) as part of the companys
  ongoing international growth
• In July 2019, Marken acquired HRTL (Italy), HETO
  (Austria), and Der Kurier (Hungary) to further
  strengthen its commitment to providing logistics
  services to the pharmaceutical and life sciences
  industries in Europe

5
Competitive Landscape Analysis of Clinical Trial
Supplies Market The global clinical trial
supplies market is highly fragmented with the
presence of large, integrated CDMOs as well as
smaller players. CROs are also looking to expand
their service scope to clinical trial
manufacturing and also clinical trial supplies
distribution logistics as a vertical
integration strategy. Some of the key/promising
players in clinical trial supplies market
include Thermo Fisher Scientific, Catalent,
Parexel, Almac Group, Clinigen, Marken (UPS),
Piramal, UDG Healthcare, Klifo, Capsugel (Lonza),
Recipharm, N-SIDE, Ancillare, and Biocair. For
More Detailed Insights, Contact Us
_at_ https//meditechinsights.com/contact-us/ About
Medi-Tech Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com